Cost effectiveness of a benzodiazepine vs a nonbenzodiazepine-based sedation regimen for mechanically ventilated, critically ill adults

Journal of Critical Care

Volumn 29, Issue 5, 2014, Pages 753-757

  Bioc, Justin J ^a   Magee, Chelsea ^a   Cucchi, James ^a   Fraser, Gilles L ^b   Dasta, Joseph F ^c   Edwards, Roger A ^a   Devlin, John W ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MAINE MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Cost effectiveness; Dexmedetomidine; Intensive care unit; Lorazepam; Midazolam; Propofol

Indexed keywords

DEXMEDETOMIDINE; LORAZEPAM; MIDAZOLAM; PROPOFOL; BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

ARTICLE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DRUG COST; EXTUBATION; HIDDEN MARKOV MODEL; HOSPITAL COST; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; ONSET AGE; SEDATION; SURGICAL PATIENT; TREATMENT DURATION; VENTILATED PATIENT; ARTIFICIAL VENTILATION; COST BENEFIT ANALYSIS; SENSITIVITY ANALYSIS; ADULT; CLINICAL PROTOCOL; ECONOMICS; PROBABILITY; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ADULT; BENZODIAZEPINES; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; DEXMEDETOMIDINE; DRUG COSTS; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; MARKOV CHAINS; PROPOFOL; RESPIRATION, ARTIFICIAL; SENSITIVITY AND SPECIFICITY;

EID: 84906069865     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.05.020     Document Type: Article

References (34)

1. Hughes C.G., McGrane S., Pandharipande P.P. Sedation in the intensive care setting. Clin Pharmacol 2012, 4:53-63.
2. Barr J., Fraser G.L., Puntillo K., et al. Clinical practice guidelines for the management of pain, agitation and delirium in the adult ICU paitents. Crit Care Med 2013, 41:263-306.
3. Weinbroum A.A., Halpern P., Rudick V., Sorkine P., Freedman M., Geller E. Midazolam versus propofol or long-term sedation in the ICU: a randomized prospective comparison. Intensive Care Med 1997, 23:1258-1263.
4. Carson S.S., Kress J.P., Rodgers J.E., et al. A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med 2006, 34:1326-1332.
5. Pandharipande P.P., Pun B.T., Herr H.L., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298(22):2644-2653.
6. Riker R.R., Shehabi Y., Bokesch P.M., et al. Dexmedetomidine vs midazolam for sedation of critically ill patients. JAMA 2009, 301:489-499.
7. Roukonen E., Parvianinen I., Jakob S.M., et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009, 35:282-290.
8. Jakob S.M., Ruokonen E., Grounds R.M., et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation. JAMA 2012, 307:1151-1160.
9. Wunsch H., Kahn J.M., Kramer A.A., Rubenfeld G.D. Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 2009, 37:3031-3039.
10. Devlin J.W., Roberts R.J. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin 2009, 25:431-449.
11. Girard T.D., Kress J.P., Fuchs B.D., et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008, 371:126-134.
12. Hager D.N., Dinglas V.D., Subhas S., et al. Reducing deep sedation and delirium in acute lung injury patients: a quality improvement project. Crit Care Med 2013, 41(6):1435-1442.
13. Skrobik Y., Leger C., Cossette M., Michaud V., Turgeon J. Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med 2013, 41(4):999-1008.
14. Fraser G.L., Worby C.P., Riker R.R. Dissecting sedation-induced delirium. Crit Care Med 2013, 41(4):1144-1146.
15. Zaal I., Devlin J.W., van der Kooi A., et al. The association between benzodiazepine use and delirium in the ICU: a prospective cohort study. Crit Care Med 2013, 41(Suppl 2):A851.
16. Ely E.W., Dittus R.S., Girard T.D. Point: should benzodiazepines be avoided in mechanically ventilated patients? Yes. Chest 2012, 142(2):281-284. [discussion 289-90].
17. Skrobik Y. Counterpoint: should benzodiazepines be avoided in mechanically ventilated patients? No. Chest 2012, 142(2):284-287. [discussion 287-9].
18. Devlin J.W., Fraser G.L., Ely E.W., Kress J.P., Skrobik Y., Dasta J.F. Pharmacological management of sedation and delirium in mechanically ventilated ICU patients: remaining evidence gaps and controversies. Semin Respir Crit Care Med 2013, 34(2):201-215.
19. Anis A.H., Wang X.H., Leon H., et al. Propofol Study Group: economic evaluation of propofol for sedation of patients admitted to intensive care units. Anesthesiology 2002, 96:196-201.
20. Cox C.E., Reed S.D., Govert J.A., et al. Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. Crit Care Med 2008, 36:706-714.
21. Dasta J.F., Kane-Gill S.L., Pencina M., et al. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med 2010, 38:497-503.
22. Lachaine J., Beauchemin C. Economic evaluation of dexmedetomidine relative to midazolam for sedation in the intensive care unit. Can J Hosp Pharm 2012, 65:103-110.
23. Dasta J.F., Kane-Gill S. Pharmacoeconomics of sedation in the ICU. Crit Care Clin 2009, 25(3):571-583.
24. Fraser G.L., Devlin J.W., Worby C.P., et al. Benzodiazepine versus non-benzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med 2013, 41(Suppl 1):S30-S38.
25. Husereau D., Drummond M., Petrou S., et al. ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 2013, 16(2):231-250.
26. Dasta J.F., McLaughlin T.P., Mody S.H., Piech C.T. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med 2005, 33:1266-1271.
27. Lexi-Comp Online, Lexi-Drugs Online, Hudson 2013, Lexi-Comp, Inc., Ohio, [October 25, 2013].
28. Mansley E.C., Carroll N.V., Chen K.S., et al. Good research practices for measuring drug costs in cost-effectiveness analyses: a managed care perspective: the ISPOR drug cost task force report-part III. Value Health 2010, 13:14-17.
29. McGhan W.F., Al M., Doshi J.A., et al. The ISPOR good practices for quality improvement of cost-effectiveness research task force report. Value Health 2009, 12:1086-1099.
30. Patel S.B., Poston J.T., Pohlman A., Hall J.B., Kress J.P. Rapidly reversible, sedation-related delirium versus persistent delirium in the intensive care unit. Am J Respir Crit Care Med 2014, 198:658-665.
31. Devlin J.W., Fraser G.L., Joffe A.M., Riker R.R., Skrobik Y. The accurate recognition of delirium in the ICU: the emperor's new clothes?. Intensive Care Med 2013, 39(12):2196-2199.
32. Devlin J.W., Mallow-Corbett S., Riker R.R. Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med 2010, 38(6 Suppl):S231-S243.
33. Kahn J.M., Rubenfeld G.D., Rohrbach J., Fuchs B.D. Cost savings attributed to reductions in intensive care unit length of stay for mechanically ventilated patients. Med Care 2008, 46:1226-1233.
34. Greenspun H., Bercik W. Cost-outcomes focus is essential for ACO success. Healthc Financ Manage 2013, 67(2):96-102.